Skip to content
777 Sourcing.

Capability

genome-wide mapping

Suppliers
1
States & provinces
1
Countries
1

1 genome-wide mapping supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Ikaika Therapeutics is a biotech company developing first-in-class anti-fibrotic antibodies, including IKN-001, which binds LTBP4 to prevent TGF-β activation and fibrosis accumulation. Its pipeline targets fibrotic diseases including muscular dystrophy, based on genetic research identifying LTBP4 as a driver of fibrotic disease severity.

antibody developmentgenetic researchquantitative trait loci mapping

Related capabilities

Other processes offered by the shops that list genome-wide mapping.

Browse all capabilities